Trial Profile
Pharmacokinetics of and Rate of HIV-1 RNA Decline in ARV-naive HIV-1 Infected Patients Treated With Low- or Standard-dose Saquinavir HGC (Invirase) and Lopinavir/Ritonavir (Kaletra).
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Feb 2022
Price :
$35
*
At a glance
- Drugs Lopinavir/ritonavir (Primary) ; Saquinavir (Primary)
- Indications HIV-1 infections
- Focus Pharmacokinetics; Therapeutic Use
- 05 Dec 2006 New trial record.